TABLE 3.

Earliest visit with response achieved for responders‐FAS

	Number (%) of patients
Time points	Ig‐naïveN = 16	Ig‐pre‐treatedN = 16	OverallN = 32
Week 3‐before the second course	2 (12.5%)	5 (31.3%)	7 (21.9%)
Week 6‐before the third course	2 (12.5%)	4 (25.0%)	6 (18.8%)
Week 9‐before the fourth course	2 (12.5%)	3 (18.8%)	5 (15.6%)
Week 12‐before the fifth course	1 (6.3%)	1 (6.3%)	2 (6.3%)
Week 15‐before the sixth course	2 (12.5%)	1 (6.3%)	3 (9.4%)
Week 18‐before the seventh course	3 (18.8%)	1 (6.3%)	4 (12.5%)
Week 21‐before the eighth course	2 (12.5%)	1 (6.3%)	3 (9.4%)
Week 24 (EOS)‐after the eighth course	2 (12.5%)	0	2 (6.3%)

Abbreviations: EOS, end of study; FAS, full analysis set.